The New England Journal of Medicine8 天
Pembrolizumab in Muscle-Invasive Urothelial Carcinoma
The immune checkpoint inhibitor pembrolizumab may reduce this risk. New research findings are summarized in a short video.
Nasdaq1 个月
Revolution Medicines provides updates from RAS(ON) inhibitor combo studies
RAS(ON) Inhibitor Combination Studies: RMC-6236 with Pembrolizumab: RMC-LUNG-101B is an arm of the Phase 1b study of RMC-6236 in combination with pembrolizumab, with or without chemotherapy ...